elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48272997-E3ECA03E-033F-4DE7-AD85-FAAD08CD4A43
Q48272997-E3ECA03E-033F-4DE7-AD85-FAAD08CD4A43
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48272997-E3ECA03E-033F-4DE7-AD85-FAAD08CD4A43
Risk of febrile neutropenia and early treatment cessation in men receiving standard and dose-reduced 3-weekly docetaxel for metastatic castration-resistant prostate cancer.
P1476
Q48272997-E3ECA03E-033F-4DE7-AD85-FAAD08CD4A43
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48272997-E3ECA03E-033F-4DE7-AD85-FAAD08CD4A43
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d5775c15fd713b5743132c979d5da7c6f8980f84
P1476
Risk of febrile neutropenia an
......
tion-resistant prostate cancer
@en